Cargando…
Translation of IDEA trial results into clinical practice: Analysis of the implementation of a new guideline for colon cancer
The IDEA trial showed no clinical relevant differences in efficacy between 3 and 6 months of oxaliplatin‐based adjuvant chemotherapy (ACT) in colon cancer (CC), while toxicity was substantially lower in the 3 months regimen. Therefore, in 2017 the Dutch colorectal cancer guideline was revised and cu...
Autores principales: | van Rooijen, Karlijn L., Derksen, Jeroen W. G., Verkooijen, Helena M., Vink, Geraldine R., Koopman, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545923/ https://www.ncbi.nlm.nih.gov/pubmed/35657640 http://dx.doi.org/10.1002/ijc.34149 |
Ejemplares similares
-
Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data
por: Jongeneel, Gabrielle, et al.
Publicado: (2019) -
Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort study
por: Jongeneel, Gabrielle, et al.
Publicado: (2021) -
Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data
por: Hamers, Patricia A. H., et al.
Publicado: (2020) -
Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis
por: van der Kruijssen, Dave E. W., et al.
Publicado: (2022) -
Alcohol consumption, cigarette smoking and cancer of unknown primary risk: Results from the Netherlands Cohort Study
por: Hermans, Karlijn E. P. E., et al.
Publicado: (2020)